Author
Branko Stanovnik
Bio: Branko Stanovnik is an academic researcher from University of Ljubljana. The author has contributed to research in topics: Alkyl & Cycloaddition. The author has an hindex of 18, co-authored 187 publications receiving 1186 citations.
Topics: Alkyl, Cycloaddition, Ring (chemistry), Pyridine, Pyridazine
Papers published on a yearly basis
Papers
More filters
57 citations
TL;DR: In this paper, aplysinopsin analogues were prepared by a simple coupling of N, N -(dimethylamino)methylidene substituted hydantoin, thiohydantoin and thiazolone derivatives, with indole derivatives.
40 citations
TL;DR: Methyl 2-(benzyloxycarbonyl)aimno-3-dimemylaminopropenoate (2) was prepared from methyl N-(bensyloxy carbonyl)-glycinate (1) and t-butoxybis(dimethylamino)methane, and used as a reagent for preparation of substituted 3-amino compounds 7, 8, 20, 36, 38 and 53-57 in yields better than 80% as discussed by the authors.
38 citations
TL;DR: Microwave-assisted cycloaddition of (E)-3-dimethylamino-1-heteroaryl-prop-2-en-1ones to dimethyl acetylenedicarboxylates gives (2E,3E)-dimethyl-2-[(dimethyamino)methylene]-3-(substituted)succinates in 8-91% yield as mentioned in this paper.
37 citations
TL;DR: N-Protected (Z)-3-(arylamino)-2,3-dehydroalanine esters 5 and 10 were prepared in one step from methyl (Z)2-acylamino-3-(dimethylamino)prop-2-enoates 3 and 9 and anilines 4 employing a parallel solution-phase synthetic approach.
Abstract: N-Protected (Z)-3-(arylamino)-2,3-dehydroalanine esters 5 and 10 were prepared in one step from methyl (Z)-2-acylamino-3-(dimethylamino)prop-2-enoates 3 and 9 and anilines 4 employing a parallel solution-phase synthetic approach. In most cases, analytically pure products 5 and 10 were obtained. On the other hand, a three-step parallel solid-phase synthesis of 2-acetylamino-4H-azino[1,2-x]pyrimidin-4-ones 15 via the polymer-bound methyl (Z)-2-acetylamino-3-(dimethylamino)prop-2-enoate (12) was also developped.
32 citations
Cited by
More filters
1,661 citations
448 citations
430 citations
Patent•
12 Aug 2004TL;DR: In this paper, pharmaceuticals, kits and methods for use with DPP-IV and other S9 proteases that comprise a compound comprising of CO, SO, SO 2, and C═NR 9 are described.
Abstract: Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a compound comprising:
wherein M is N or CR 4 ; Q 1 and Q 2 are each independently selected from the group consisting of CO, SO, SO 2 , and C═NR 9 ; and each L, X, R 1 , R 2 , and R 3 are as defined herein.
339 citations